ArticleFrontiers in immunology2026
Case Report: Complete hydatidiform mole mimicking spondyloarthritis: a probable paraneoplastic rheumatologic syndrome.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Complete hydatidiform mole (CHM) is a gestational trophoblastic disease characterized by abnormal proliferation of trophoblastic tissue and markedly elevated β-human chorionic gonadotropin (β-hCG) levels. Although CHM typically presents with vaginal bleeding and uterine enlargement, it may occasionally manifest with paraneoplastic systemic symptoms that mimic autoimmune rheumatic diseases. Case presentation: A 33-year-old woman presented with a 2-month history of polyarthritis, inflammatory low back pain, and morning stiffness, initially suspected as spondyloarthritis (SpA). She had a history of missed miscarriage at 7 weeks of gestation with medical abortion two months prior. Physical examination revealed dactylitis of the left third finger and right fifth toe, enthesitis at bilateral heels, and tenderness over the lumbar spine. Laboratory tests showed elevated erythrocyte sedimentation rate (50 mm/h) and C-reactive protein (42.8 mg/L). HLA-B27 was positive, while rheumatoid factor, anti-cyclic citrullinated peptide antibodies, and antinuclear antibodies were negative. Pelvic ultrasonography revealed a heterogeneous echogenic intrauterine mass (4.8 × 4.3 × 3.6 cm) with a "honeycomb" or "snowstorm" appearance, suggestive of gestational trophoblastic disease. Serum β-hCG was markedly elevated at 31,870 IU/L. Bone scintigraphy demonstrated increased uptake in the left wrist, metacarpophalangeal joints, interphalangeal joints, left ankle, and L1 spinous process. Uterine curettage was performed, and histopathology confirmed complete hydatidiform mole. Following the procedure, arthralgia and back pain resolved dramatically without disease-modifying antirheumatic drugs or biologics. Serum β-hCG declined progressively to normal levels, and inflammatory markers normalized. At 2-year follow-up, the patient remained asymptomatic, and repeat bone scintigraphy showed no abnormal uptake. Conclusion: This case highlights that CHM can present with rheumatic manifestations mimicking SpA, including inflammatory back pain, peripheral arthritis, dactylitis, enthesitis, and even HLA-B27 positivity. The parallel course of rheumatic symptoms with β-hCG levels, rapid resolution after uterine evacuation, and sustained remission during follow-up are consistent with a probable paraneoplastic rheumatologic syndrome rather than primary SpA. Clinicians should maintain a high index of suspicion for gestational trophoblastic disease in women of childbearing age presenting with new-onset inflammatory arthritis and elevated β-hCG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.